BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25135164)

  • 1. Epigenetic marks in estrogen receptor alpha CpG island correlate with some reproductive risk factors in breast cancer.
    Izadi P; Noruzinia M; Fereidooni F; Mostakhdemine Hosseini Z; Kamali F
    Mol Biol Rep; 2014 Nov; 41(11):7607-12. PubMed ID: 25135164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
    Zhao L; Wang L; Jin F; Ma W; Ren J; Wen X; He M; Sun M; Tang H; Wei M
    Breast Cancer Res Treat; 2009 Sep; 117(2):253-9. PubMed ID: 18814026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha (ERα) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients.
    Hagrass HA; Pasha HF; Ali AM
    Gene; 2014 Nov; 552(1):81-6. PubMed ID: 25218234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
    Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
    PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
    Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
    Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
    Gaudet MM; Campan M; Figueroa JD; Yang XR; Lissowska J; Peplonska B; Brinton LA; Rimm DL; Laird PW; Garcia-Closas M; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3036-43. PubMed ID: 19861523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
    Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
    Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
    Izadi P; Mehrdad N; Foruzandeh F; Reza NM
    Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
    Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
    Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
    J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A methylation signature at the CpG island promoter of estrogen receptor beta (ER-β) in breasts of women may be an early footmark of lack of breastfeeding and nulliparity.
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Roshan SJ; Bayani N; Tavakkoly-Bazzaz J
    Pathol Res Pract; 2021 Feb; 218():153328. PubMed ID: 33422777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
    Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
    Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
    Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.
    Buchegger K; Riquelme I; Viscarra T; Ili C; Brebi P; Huang TH; Roa JC
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28809778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.